Lonza Group Ltd (Lonza) is a manufacturer of active pharmaceutical ingredients, both chemically and biotechnologically. It also provides microbial control. The company harnesses its proprietary technologies, increase in working capital, and increased revenues to sustain its leading market position. However, existing lawsuits could be a major cause for concern to the company. Strategic contracts and agreements, the launch of new products, and growth prospects in pharmaceutical outsourcing could provide growth opportunities to the company. However, increasing competitive pressure and stringent government regulations could affect the company’s business operations and profitability.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer